Friday, October 28, 2016

Dexametasona Indukern




Dexametasona Indukern may be available in the countries listed below.


Ingredient matches for Dexametasona Indukern



Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Dexametasona Indukern in the following countries:


  • Spain

International Drug Name Search


Ovispec




Ovispec may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ovispec



Albendazole

Albendazole is reported as an ingredient of Ovispec in the following countries:


  • United Kingdom

International Drug Name Search


Vitole E




Vitole E may be available in the countries listed below.


Ingredient matches for Vitole E



Tocopherol, α-

Tocopherol, α- is reported as an ingredient of Vitole E in the following countries:


  • Poland

International Drug Name Search


Dobupum




Dobupum may be available in the countries listed below.


Ingredient matches for Dobupum



Dobutamine

Dobutamine is reported as an ingredient of Dobupum in the following countries:


  • Japan

International Drug Name Search


Salamol




Salamol may be available in the countries listed below.


Ingredient matches for Salamol



Salbutamol

Salbutamol is reported as an ingredient of Salamol in the following countries:


  • Georgia

  • Romania

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Salamol in the following countries:


  • Denmark

  • Malta

  • New Zealand

  • Switzerland

  • United Kingdom

International Drug Name Search


Sterapred




In the US, Sterapred (prednisone systemic) is a member of the drug class glucocorticoids and is used to treat Acute Lymphocytic Leukemia, Adrenocortical Insufficiency, Adrenogenital Syndrome, Allergic Reactions, Ankylosing Spondylitis, Aspiration Pneumonia, Asthma, Atopic Dermatitis, Autoimmune Hemolytic Anemia, Berylliosis, Bullous Pemphigoid, Bursitis, Chorioretinitis, Cluster Headaches, Cogan's Syndrome, Conjunctivitis - Allergic, Corneal Ulcer, Dermatitis Herpetiformis, Dermatomyositis, Eczema, Epicondylitis - Tennis Elbow, Erythroblastopenia, Fibromyalgia, Gouty Arthritis, Graft-versus-host disease, Hay Fever, Herpes Zoster, Herpes Zoster Iridocyclitis, Hypercalcemia of Malignancy, Idiopathic Thrombocytopenic Purpura, Immunosuppression, Inflammatory Conditions, Iridocyclitis, Iritis, Juvenile Rheumatoid Arthritis, Keratitis, Leukemia, Lichen Planus, Lichen Sclerosus, Loeffler's Syndrome, Lymphoma, Multiple Sclerosis, Mycosis Fungoides, Nephrotic Syndrome, Neurosarcoidosis, Osteoarthritis, Pemphigoid, Pemphigus, Pharyngitis, Polymyositis/Dermatomyositis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Sarcoidosis, Seborrheic Dermatitis, Sinusitis, Skin Rash, Synovitis, Systemic Lupus Erythematosus, Systemic Sclerosis, Thrombocytopenia, Toxic Epidermal Necrolysis, Tuberculosis - Extrapulmonary, Tuberculous Meningitis, Ulcerative Colitis and Uveitis - Posterior.

US matches:

  • Sterapred

  • Sterapred DS

Ingredient matches for Sterapred



Prednisone

Prednisone is reported as an ingredient of Sterapred in the following countries:


  • United States

International Drug Name Search


Agrylin


Agrylin is a brand name of anagrelide, approved by the FDA in the following formulation(s):


AGRYLIN (anagrelide hydrochloride - capsule; oral)



  • Manufacturer: SHIRE LLC

    Approval date: March 14, 1997

    Strength(s): EQ 0.5MG BASE [AB]

Has a generic version of Agrylin been approved?


Yes. The following products are equivalent to Agrylin:


anagrelide hydrochloride capsule; oral



  • Manufacturer: ALPHAPHARM

    Approval date: June 27, 2006

    Strength(s): EQ 0.5MG BASE [AB]


  • Manufacturer: BARR

    Approval date: April 18, 2005

    Strength(s): EQ 0.5MG BASE [AB]


  • Manufacturer: IMPAX LABS

    Approval date: April 18, 2005

    Strength(s): EQ 0.5MG BASE [AB]


  • Manufacturer: IVAX SUB TEVA PHARMS

    Approval date: April 18, 2005

    Strength(s): EQ 0.5MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: April 18, 2005

    Strength(s): EQ 0.5MG BASE [AB]


  • Manufacturer: SANDOZ

    Approval date: April 18, 2005

    Strength(s): EQ 0.5MG BASE [AB]


  • Manufacturer: WATSON LABS

    Approval date: April 18, 2005

    Strength(s): EQ 0.5MG BASE [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Agrylin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Agrylin.

See also...

  • Agrylin Consumer Information (Wolters Kluwer)
  • Agrylin Consumer Information (Cerner Multum)
  • Agrylin Advanced Consumer Information (Micromedex)
  • Agrylin AHFS DI Monographs (ASHP)
  • Anagrelide Consumer Information (Wolters Kluwer)
  • Anagrelide Consumer Information (Cerner Multum)
  • Anagrelide Advanced Consumer Information (Micromedex)
  • Anagrelide hydrochloride AHFS DI Monographs (ASHP)

Thursday, October 27, 2016

Orthon




Orthon may be available in the countries listed below.


Ingredient matches for Orthon



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Orthon in the following countries:


  • Greece

International Drug Name Search


Humalog Mix




Humalog Mix may be available in the countries listed below.


Ingredient matches for Humalog Mix



Insulin Lispro

Insulin Lispro is reported as an ingredient of Humalog Mix in the following countries:


  • Bulgaria

Insulin Lispro biphasic (a derivative of Insulin Lispro) is reported as an ingredient of Humalog Mix in the following countries:


  • Aruba

  • Bahamas

  • Barbados

  • Bermuda

  • Cayman Islands

  • Haiti

  • Jamaica

  • Netherlands Antilles

  • Trinidad & Tobago

International Drug Name Search


Dilyt




Dilyt may be available in the countries listed below.


Ingredient matches for Dilyt



Ambroxol

Ambroxol is reported as an ingredient of Dilyt in the following countries:


  • Bangladesh

International Drug Name Search


Nycoplus C-vitamin




Nycoplus C-vitamin may be available in the countries listed below.


Ingredient matches for Nycoplus C-vitamin



Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Nycoplus C-vitamin in the following countries:


  • Norway

International Drug Name Search


Srendam




Srendam may be available in the countries listed below.


Ingredient matches for Srendam



Suprofen

Suprofen is reported as an ingredient of Srendam in the following countries:


  • Japan

International Drug Name Search


Dixi




Dixi may be available in the countries listed below.


Ingredient matches for Dixi



Cyproterone

Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Dixi in the following countries:


  • Venezuela

International Drug Name Search


Roxro Pharma, Inc


Address


Roxro Pharma, Inc.,
535 Middlefield Road

Suite 180

Menlo Park, CA 94025

Contact Details

Phone: (650) 322-4554
Website: http://www.roxropharma.com/

Deprexan




Deprexan may be available in the countries listed below.


Ingredient matches for Deprexan



Desipramine

Desipramine hydrochloride (a derivative of Desipramine) is reported as an ingredient of Deprexan in the following countries:


  • Israel

International Drug Name Search


Zyban




In the US, Zyban (bupropion systemic) is a member of the drug class smoking cessation agents and is used to treat Smoking Cessation.

US matches:

  • Zyban

  • Zyban Sustained-Release Tablets

  • Zyban Advantage Pack

UK matches:

  • Zyban 150 mg prolonged release film-coated tablets (SPC)

Ingredient matches for Zyban



Bupropion

Bupropion hydrochloride (a derivative of Bupropion) is reported as an ingredient of Zyban in the following countries:


  • Australia

  • Austria

  • Belgium

  • Bosnia & Herzegowina

  • Brazil

  • Canada

  • Czech Republic

  • Denmark

  • Estonia

  • Finland

  • France

  • Germany

  • Guyana

  • Hong Kong

  • Iceland

  • India

  • Ireland

  • Israel

  • Italy

  • Latvia

  • Luxembourg

  • Malta

  • Netherlands

  • New Zealand

  • Norway

  • Oman

  • Poland

  • Portugal

  • Romania

  • Serbia

  • Singapore

  • Slovenia

  • South Africa

  • Sweden

  • Switzerland

  • Taiwan

  • Turkey

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, October 26, 2016

Docsalbuta




Docsalbuta may be available in the countries listed below.


Ingredient matches for Docsalbuta



Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Docsalbuta in the following countries:


  • Belgium

International Drug Name Search


Scopinal




Scopinal may be available in the countries listed below.


Ingredient matches for Scopinal



Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Scopinal in the following countries:


  • Oman

International Drug Name Search


Zerpex




Zerpex may be available in the countries listed below.


Ingredient matches for Zerpex



Brivudine

Brivudine is reported as an ingredient of Zerpex in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search


Valproate de sodium Merck




Valproate de sodium Merck may be available in the countries listed below.


Ingredient matches for Valproate de sodium Merck



Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Valproate de sodium Merck in the following countries:


  • France

International Drug Name Search


Disopyra-R




Disopyra-R may be available in the countries listed below.


Ingredient matches for Disopyra-R



Disopyramide

Disopyramide is reported as an ingredient of Disopyra-R in the following countries:


  • Japan

International Drug Name Search


Salbutan




Salbutan may be available in the countries listed below.


Ingredient matches for Salbutan



Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Salbutan in the following countries:


  • Venezuela

International Drug Name Search


Dytide




Dytide may be available in the countries listed below.


Ingredient matches for Dytide



Benzthiazide

Benzthiazide is reported as an ingredient of Dytide in the following countries:


  • United Kingdom

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Dytide in the following countries:


  • Germany

Triamterene

Triamterene is reported as an ingredient of Dytide in the following countries:


  • Germany

  • United Kingdom

International Drug Name Search


Activella


Activella is a brand name of estradiol/norethindrone, approved by the FDA in the following formulation(s):


ACTIVELLA (estradiol; norethindrone acetate - tablet; oral)



  • Manufacturer: NOVO NORDISK INC

    Approval date: November 18, 1998

    Strength(s): 1MG;0.5MG [RLD][AB]


  • Manufacturer: NOVO NORDISK INC

    Approval date: December 28, 2006

    Strength(s): 0.5MG;0.1MG [AB]

Has a generic version of Activella been approved?


Yes. The following products are equivalent to Activella:


ESTRADIOL AND NORETHINDRONE ACETATE (estradiol; norethindrone acetate tablet; oral)



  • Manufacturer: BARR

    Approval date: May 11, 2010

    Strength(s): 1MG;0.5MG [AB]


  • Manufacturer: BRECKENRIDGE PHARM

    Approval date: April 17, 2008

    Strength(s): 1MG;0.5MG [AB]


  • Manufacturer: BRECKENRIDGE PHARM

    Approval date: June 9, 2011

    Strength(s): 0.5MG;0.1MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Activella. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Activella.

See also...

  • Activella Consumer Information (Wolters Kluwer)
  • Activella Consumer Information (Cerner Multum)
  • Estradiol/Norethindrone Consumer Information (Wolters Kluwer)
  • Estradiol/Norethindrone Patch (Bi-weekly) Consumer Information (Wolters Kluwer)
  • Estradiol and norethindrone Consumer Information (Cerner Multum)
  • Estradiol and norethindrone topical patches Consumer Information (Cerner Multum)

Dermocinetic




Dermocinetic may be available in the countries listed below.


Ingredient matches for Dermocinetic



Escin

Escin is reported as an ingredient of Dermocinetic in the following countries:


  • Italy

Levothyroxine

Levothyroxine sodium salt (a derivative of Levothyroxine) is reported as an ingredient of Dermocinetic in the following countries:


  • Italy

International Drug Name Search


Distedon




Distedon may be available in the countries listed below.


Ingredient matches for Distedon



Clidinium

Clidinium Bromide is reported as an ingredient of Distedon in the following countries:


  • Greece

Diazepam

Diazepam is reported as an ingredient of Distedon in the following countries:


  • Greece

International Drug Name Search


Tobradex ST


See also: Generic TobraDex


Tobradex ST is a brand name of dexamethasone/tobramycin ophthalmic, approved by the FDA in the following formulation(s):


TOBRADEX ST (dexamethasone; tobramycin - suspension/drops; ophthalmic)



  • Manufacturer: ALCON PHARMS LTD

    Approval date: February 13, 2009

    Strength(s): 0.05%;0.3% [RLD]

Has a generic version of Tobradex ST been approved?


No. There is currently no therapeutically equivalent version of Tobradex ST available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tobradex ST. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Topical ophthalmic compositions containing tobramycin and dexamethasone
    Patent 7,795,316
    Issued: September 14, 2010
    Inventor(s): Kabra; Bhagwati P.
    Assignee(s): Alcon Research, Ltd.
    Ophthalmic pharmaceutical compositions containing tobramycin, dexamethasone and deacetylated xanthan gum are described. The compositions provide longer ocular retention for enhanced ocular bioavailability of tobramycin and dexamethasone. In a preferred embodiment, the compositions also provide for improved suspension of dexamethasone. The concentration of ionizable species in the compositions is controlled so as to prevent precipitation of the xanthan gum as a result of ionic interactions between tobramycin and xanthan gum, while allowing for a restoration of viscosity upon topical application of the compositions to the eye. The use of deacetylated xanthan gum is disclosed, so as to avoid formulation instability caused by pH drift during storage.
    Patent expiration dates:

    • August 3, 2028
      ✓ 
      Patent use: USE OF A COMBINATION OF TOBRAMYCIN AND DEXAMETHASONE TO TREAT OCULAR INFLAMMATION WHERE AN INFECTION OR RISK OF INFECTION EXISTS
      ✓ 
      Drug product



See also...

  • TobraDex ST Drops Consumer Information (Wolters Kluwer)
  • Tobradex ST Advanced Consumer Information (Micromedex)
  • Tobramycin/Dexamethasone Drops Consumer Information (Wolters Kluwer)
  • Tobramycin/Dexamethasone Ointment Consumer Information (Wolters Kluwer)
  • Tobramycin and dexamethasone ophthalmic Consumer Information (Cerner Multum)
  • Tobramycin and dexamethasone Ophthalmic Advanced Consumer Information (Micromedex)

Sertralin Copyfarm




Sertralin Copyfarm may be available in the countries listed below.


Ingredient matches for Sertralin Copyfarm



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralin Copyfarm in the following countries:


  • Denmark

  • Finland

International Drug Name Search


Herpes Zoster Peripheral Neuropathy Medications


There are currently no drugs listed for "Herpes Zoster Peripheral Neuropathy".

Learn more about Herpes Zoster Peripheral Neuropathy





Drug List:


Tuesday, October 25, 2016

Nifedipin ret-1A Pharma




Nifedipin ret-1A Pharma may be available in the countries listed below.


Ingredient matches for Nifedipin ret-1A Pharma



Nifedipine

Nifedipine is reported as an ingredient of Nifedipin ret-1A Pharma in the following countries:


  • Germany

International Drug Name Search


Zitoxil




Zitoxil may be available in the countries listed below.


Ingredient matches for Zitoxil



Minoxidil

Minoxidil is reported as an ingredient of Zitoxil in the following countries:


  • Venezuela

International Drug Name Search


Oestring




Oestring may be available in the countries listed below.


Ingredient matches for Oestring



Estradiol

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Oestring in the following countries:


  • Sweden

International Drug Name Search


Oncotaxel




Oncotaxel may be available in the countries listed below.


Ingredient matches for Oncotaxel



Docetaxel

Docetaxel trihydrate (a derivative of Docetaxel) is reported as an ingredient of Oncotaxel in the following countries:


  • Colombia

International Drug Name Search


Monday, October 24, 2016

Detrol




In the US, Detrol (tolterodine systemic) is a member of the drug class urinary antispasmodics and is used to treat Overactive Bladder and Urinary Incontinence.

US matches:

  • Detrol

  • Detrol LA Extended-Release Capsules

  • Detrol LA

Ingredient matches for Detrol



Tolterodine

Tolterodine tartrate (a derivative of Tolterodine) is reported as an ingredient of Detrol in the following countries:


  • Canada

  • United States

International Drug Name Search


Volon




Volon may be available in the countries listed below.


Ingredient matches for Volon



Triamcinolone

Triamcinolone is reported as an ingredient of Volon in the following countries:


  • Austria

  • Germany

International Drug Name Search


Duro Tuss Chesty Cough Plus Nasal Decongestant




Duro Tuss Chesty Cough Plus Nasal Decongestant may be available in the countries listed below.


Ingredient matches for Duro Tuss Chesty Cough Plus Nasal Decongestant



Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Duro Tuss Chesty Cough Plus Nasal Decongestant in the following countries:


  • New Zealand

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Duro Tuss Chesty Cough Plus Nasal Decongestant in the following countries:


  • New Zealand

International Drug Name Search


Stalcare




Stalcare may be available in the countries listed below.


Ingredient matches for Stalcare



Domperidone

Domperidone is reported as an ingredient of Stalcare in the following countries:


  • Italy

International Drug Name Search


Sarteg HCT




Sarteg HCT may be available in the countries listed below.


Ingredient matches for Sarteg HCT



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Sarteg HCT in the following countries:


  • Bulgaria

Valsartan

Valsartan is reported as an ingredient of Sarteg HCT in the following countries:


  • Bulgaria

International Drug Name Search


Unitron




Unitron may be available in the countries listed below.


Ingredient matches for Unitron



Peginterferon Alfa 2-a

Peginterferon Alfa 2-a is reported as an ingredient of Unitron in the following countries:


  • Canada

International Drug Name Search


Novolin Flexpen 50R




Novolin Flexpen 50R may be available in the countries listed below.


Ingredient matches for Novolin Flexpen 50R



Insulin Injection, Biphasic Isophane

Insulin Injection, Biphasic Isophane human (a derivative of Insulin Injection, Biphasic Isophane) is reported as an ingredient of Novolin Flexpen 50R in the following countries:


  • China

International Drug Name Search


Sunday, October 23, 2016

Nichidopa




Nichidopa may be available in the countries listed below.


Ingredient matches for Nichidopa



Methyldopa

Methyldopa sesquihydrate (a derivative of Methyldopa) is reported as an ingredient of Nichidopa in the following countries:


  • Japan

International Drug Name Search


Dermacortine




Dermacortine may be available in the countries listed below.


Ingredient matches for Dermacortine



Mometasone

Mometasone 17-(2-furoate) (a derivative of Mometasone) is reported as an ingredient of Dermacortine in the following countries:


  • Peru

International Drug Name Search


Venlafaxin-biomo




Venlafaxin-biomo may be available in the countries listed below.


Ingredient matches for Venlafaxin-biomo



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Venlafaxin-biomo in the following countries:


  • Germany

International Drug Name Search


Saturday, October 22, 2016

Nerisona




Nerisona may be available in the countries listed below.


Ingredient matches for Nerisona



Diflucortolone

Diflucortolone 21-valerate (a derivative of Diflucortolone) is reported as an ingredient of Nerisona in the following countries:


  • Argentina

  • Austria

  • Belgium

  • Brazil

  • Germany

  • Indonesia

  • Italy

  • Japan

  • Luxembourg

  • Netherlands

  • Peru

  • Philippines

  • Portugal

International Drug Name Search


Demoxil




Demoxil may be available in the countries listed below.


Ingredient matches for Demoxil



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Demoxil in the following countries:


  • Bangladesh

International Drug Name Search


Influenza A Medications


Definition of Influenza A: A contagious viral infection of the nose, throat and lungs which often occurs in the winter.

Drugs associated with Influenza A

The following drugs and medications are in some way related to, or used in the treatment of Influenza A. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Simvastatina Grapa




Simvastatina Grapa may be available in the countries listed below.


Ingredient matches for Simvastatina Grapa



Simvastatin

Simvastatin is reported as an ingredient of Simvastatina Grapa in the following countries:


  • Spain

International Drug Name Search


Zopiclon




Zopiclon may be available in the countries listed below.


Ingredient matches for Zopiclon



Eszopiclone

Zopiclone is reported as an ingredient of Zopiclon in the following countries:


  • Czech Republic

  • Netherlands

  • Slovakia

International Drug Name Search


Diclostar PF




Diclostar PF may be available in the countries listed below.


Ingredient matches for Diclostar PF



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclostar PF in the following countries:


  • Japan

International Drug Name Search


Siticox




Siticox may be available in the countries listed below.


Ingredient matches for Siticox



Rifampicin

Rifampicin is reported as an ingredient of Siticox in the following countries:


  • India

International Drug Name Search


Omeprazol Alternova




Omeprazol Alternova may be available in the countries listed below.


Ingredient matches for Omeprazol Alternova



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Alternova in the following countries:


  • Austria

International Drug Name Search


Oxaliplatino Teva




Oxaliplatino Teva may be available in the countries listed below.


Ingredient matches for Oxaliplatino Teva



Oxaliplatin

Oxaliplatin is reported as an ingredient of Oxaliplatino Teva in the following countries:


  • Italy

  • Spain

International Drug Name Search


Wormex




Wormex may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Wormex



Mebendazole

Mebendazole is reported as an ingredient of Wormex in the following countries:


  • Ethiopia

Praziquantel

Praziquantel is reported as an ingredient of Wormex in the following countries:


  • Australia

Pyrantel

Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Wormex in the following countries:


  • Australia

International Drug Name Search


Omeprazol Pharmacin




Omeprazol Pharmacin may be available in the countries listed below.


Ingredient matches for Omeprazol Pharmacin



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Pharmacin in the following countries:


  • Netherlands

International Drug Name Search


Friday, October 21, 2016

Ondansétron Ratiopharm




Ondansétron Ratiopharm may be available in the countries listed below.


Ingredient matches for Ondansétron Ratiopharm



Ondansetron

Ondansetron is reported as an ingredient of Ondansétron Ratiopharm in the following countries:


  • France

Ondansetron hydrochloride dihydrate (a derivative of Ondansetron) is reported as an ingredient of Ondansétron Ratiopharm in the following countries:


  • France

International Drug Name Search


Unguento Morry




Unguento Morry may be available in the countries listed below.


Ingredient matches for Unguento Morry



Salicylic Acid

Salicylic Acid is reported as an ingredient of Unguento Morry in the following countries:


  • Spain

International Drug Name Search


Sodium Nitroprusside BP




Sodium Nitroprusside BP may be available in the countries listed below.


Ingredient matches for Sodium Nitroprusside BP



Nitroprusside

Sodium Nitroprusside is reported as an ingredient of Sodium Nitroprusside BP in the following countries:


  • Australia

  • New Zealand

International Drug Name Search


Victanyl




Victanyl may be available in the countries listed below.


UK matches:

  • Victanyl 75 micrograms/hour Transdermal Patch (SPC)

Ingredient matches for Victanyl



Fentanyl

Fentanyl is reported as an ingredient of Victanyl in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Daytrana


Daytrana is a brand name of methylphenidate, approved by the FDA in the following formulation(s):


DAYTRANA (methylphenidate - film, extended release; transdermal)



  • Manufacturer: NOVEN PHARMS INC

    Approval date: April 6, 2006

    Strength(s): 10MG/9HR (1.1MG/HR), 15MG/9HR (1.6MG/HR), 20MG/9HR (2.2MG/HR), 30MG/9HR (3.3MG/HR) [RLD]

Has a generic version of Daytrana been approved?


No. There is currently no therapeutically equivalent version of Daytrana available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Daytrana. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Solubility parameter based drug delivery system and method for altering drug saturation concentration
    Patent 5,958,446
    Issued: September 28, 1999
    Inventor(s): Miranda; Jesus & Sablotsky; Steven
    Assignee(s): Noven Pharmaceuticals, Inc.
    The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.
    Patent expiration dates:

    • December 12, 2012
      ✓ 
      Drug product




  • Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
    Patent 6,210,705
    Issued: April 3, 2001
    Inventor(s): Mantelle; Juan & Dixon; Terese A.
    Assignee(s): Noven Pharmaceuticals, NC.
    The invention relates to a method of treating Attention Deficit Disorder (ADD) and Attention Deficit/Hyperactivity Disorder (ADHD) and compositions for topical application of methylphenidate comprising methylphenidate in a flexible, finite system wherein the methylphenidate is present in an amount sufficient to achieve substantially zero order kinetics for delivery to the skin or mucosa of a patient in need thereof over a period of time at least 10 hours.
    Patent expiration dates:

    • September 30, 2018
      ✓ 
      Patent use: FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
      ✓ 
      Drug product




  • Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
    Patent 6,348,211
    Issued: February 19, 2002
    Inventor(s): Juan; Mantelle & Terese A.; Dixon
    Assignee(s): Noven Pharmaceuticals, Inc.
    The invention relates to a method of treating Attention Deficit Disorder (ADD) and Attention Deficit/Hyperactivity Disorder (ADHD) and compositions for topical application of methylphenidate comprising methylphenidate in a flexible, finite system wherein the methylphenidate is present in an amount sufficient to achieve substantially zero order kinetics for delivery to the skin or mucosa of a patient in need thereof over a period of time at least 10 hours.
    Patent expiration dates:

    • September 30, 2018
      ✓ 
      Patent use: FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • June 29, 2013 - NEW PATIENT POPULATION

See also...

  • Daytrana Consumer Information (Drugs.com)
  • Daytrana System Consumer Information (Wolters Kluwer)
  • Daytrana transdermal Consumer Information (Cerner Multum)
  • Daytrana Advanced Consumer Information (Micromedex)
  • Daytrana Transdermal Advanced Consumer Information (Micromedex)
  • Methylphenidate Consumer Information (Drugs.com)
  • Methylphenidate Consumer Information (Wolters Kluwer)
  • Methylphenidate Chewable Tablets Consumer Information (Wolters Kluwer)
  • Methylphenidate Controlled-Release Capsules Consumer Information (Wolters Kluwer)
  • Methylphenidate Controlled-Release Tablets Consumer Information (Wolters Kluwer)
  • Methylphenidate Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Methylphenidate Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Methylphenidate Solution Consumer Information (Wolters Kluwer)
  • Methylphenidate System Consumer Information (Wolters Kluwer)
  • Methylphenidate Consumer Information (Cerner Multum)
  • Methylphenidate transdermal Consumer Information (Cerner Multum)
  • Methylphenidate Oral, Transdermal Advanced Consumer Information (Micromedex)
  • Methylphenidate Transdermal Advanced Consumer Information (Micromedex)
  • Methylphenidate Hydrochloride AHFS DI Monographs (ASHP)

Thursday, October 20, 2016

Oracyn-K




Oracyn-K may be available in the countries listed below.


Ingredient matches for Oracyn-K



Phenoxymethylpenicillin

Phenoxymethylpenicillin potassium (a derivative of Phenoxymethylpenicillin) is reported as an ingredient of Oracyn-K in the following countries:


  • Bangladesh

International Drug Name Search


Desenfriolito




Desenfriolito may be available in the countries listed below.


Ingredient matches for Desenfriolito



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Desenfriolito in the following countries:


  • Argentina

International Drug Name Search


Vascoten




Vascoten may be available in the countries listed below.


Ingredient matches for Vascoten



Atenolol

Atenolol is reported as an ingredient of Vascoten in the following countries:


  • Bahrain

  • Hong Kong

  • Iraq

  • Jordan

  • Malaysia

  • Romania

  • Russian Federation

  • Singapore

  • Sudan

  • Thailand

  • Tunisia

  • Yemen

International Drug Name Search


DermOtic Oil


DermOtic Oil is a brand name of fluocinolone otic, approved by the FDA in the following formulation(s):


DERMOTIC (fluocinolone acetonide - oil/drops; otic)



  • Manufacturer: HILL DERMAC

    Approval date: November 9, 2005

    Strength(s): 0.01% [RLD][AT]

Has a generic version of DermOtic Oil been approved?


Yes. The following products are equivalent to DermOtic Oil:


fluocinolone acetonide oil/drops; otic



  • Manufacturer: IDENTI PHARMS INC

    Approval date: October 17, 2011

    Strength(s): 0.01% [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of DermOtic Oil. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with DermOtic Oil.

See also...

  • DermOtic Drops Consumer Information (Wolters Kluwer)
  • Fluocinolone Drops Consumer Information (Wolters Kluwer)

Razadyne


See also: Generic Razadyne ER


Razadyne is a brand name of galantamine, approved by the FDA in the following formulation(s):


RAZADYNE (galantamine hydrobromide - solution; oral)



  • Manufacturer: JANSSEN PHARMS

    Approval date: June 22, 2001

    Strength(s): 4MG/ML [RLD][AA]

RAZADYNE (galantamine hydrobromide - tablet; oral)



  • Manufacturer: JANSSEN PHARMS

    Approval date: February 28, 2001

    Strength(s): EQ 12MG BASE [AB], EQ 4MG BASE [RLD][AB], EQ 8MG BASE [AB]

Has a generic version of Razadyne been approved?


A generic version of Razadyne has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Razadyne and have been approved by the FDA:


galantamine hydrobromide solution; oral



  • Manufacturer: ROXANE

    Approval date: January 30, 2009

    Strength(s): 4MG/ML [AA]

galantamine hydrobromide tablet; oral



  • Manufacturer: APOTEX INC

    Approval date: September 27, 2011

    Strength(s): EQ 12MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: AUROBINDO PHARMA LTD

    Approval date: March 29, 2011

    Strength(s): EQ 12MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: BARR

    Approval date: August 28, 2008

    Strength(s): EQ 12MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: DR REDDYS LABS LTD

    Approval date: September 11, 2008

    Strength(s): EQ 12MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: August 28, 2008

    Strength(s): EQ 12MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: May 29, 2009

    Strength(s): EQ 12MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: ROXANE

    Approval date: February 11, 2009

    Strength(s): EQ 12MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: SANDOZ

    Approval date: June 22, 2009

    Strength(s): EQ 12MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: TEVA PHARMS

    Approval date: July 9, 2009

    Strength(s): EQ 12MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: ZYDUS PHARMS USA INC

    Approval date: February 17, 2011

    Strength(s): EQ 12MG BASE [AB], EQ 4MG BASE [AB], EQ 8MG BASE [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Razadyne. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Fast-dissolving galanthamine hydrobromide tablet
    Patent 6,099,863
    Issued: August 8, 2000
    Inventor(s): Gilis; Paul Marie Victor & De Conde; Valentin Florent Victor
    Assignee(s): Janssen Pharmaceutica N.V.
    The present invention is concerned with a fast-dissolving tablet for oral administration comprising as an active ingredient a therapeutically effective amount of galanthamine hydrobromide (1:1) and a pharmaceutically acceptable carrier, characterized in that said carrier comprises a spray-dried mixture of lactose monohydrate and microcrystalline cellulose (75:25) as a diluent, and a disintegrant; and with a direct compression process of preparing such fast-dissolving tablets.
    Patent expiration dates:

    • June 6, 2017




  • Fast-dissolving galanthamine hydrobromide tablet
    Patent 6,358,527
    Issued: March 19, 2002
    Inventor(s): Paul Marie Victor; Gilis & Valentin Florent Victor; De Condé
    Assignee(s): Janssen Pharmaceutica N.V.
    The present invention is concerned with a fast-dissolving tablet for oral administration comprising as an active ingredient a therapeutically effective amount of galanthamine hydrobromide (1:1) and a pharmaceutically acceptable carrier, characterized in that said carrier comprises a spray dried mixture of lactose monohydrate and microcrystalline cellulose (75:25) as a diluent, and a disintegrant; and with a direct compression process of preparing such fast-dissolving tablets.
    Patent expiration dates:

    • June 6, 2017
      ✓ 
      Patent use: TREATMENT OF ALZHEIMER'S DEMENTIA
      ✓ 
      Drug product



See also...

  • Razadyne Consumer Information (Wolters Kluwer)
  • Razadyne Solution Consumer Information (Wolters Kluwer)
  • Razadyne Consumer Information (Cerner Multum)
  • Razadyne Advanced Consumer Information (Micromedex)
  • Razadyne IR Advanced Consumer Information (Micromedex)
  • Razadyne AHFS DI Monographs (ASHP)
  • Galantamine Consumer Information (Wolters Kluwer)
  • Galantamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Galantamine Solution Consumer Information (Wolters Kluwer)
  • Galantamine Consumer Information (Cerner Multum)
  • Galantamine Advanced Consumer Information (Micromedex)
  • Galantamine Hydrobromide AHFS DI Monographs (ASHP)

Nasocort




Nasocort may be available in the countries listed below.


Ingredient matches for Nasocort



Budesonide

Budesonide is reported as an ingredient of Nasocort in the following countries:


  • Israel

International Drug Name Search


Penicillins


Penicillin is an antibiotic that disturbs the cell wall synthesis in bacteria. It was initially derived from the mold Penicillium rubrum. Since then, a number of naturally occurring penicillins have been derived e.g. penicillin G (benzylpenicillin) and penicillin V (phenoxymethylpenicillin).


Other antibiotics obtained from penicillins include amoxicillin, ampicillin, flucloxacillin. These are classed as semisynthetic penicillins.


Penicillins are bactericidal and mainly active against gram-positive bacteria.


The most important side effect of penicillins is hypersensitivity, such as rashes or anaphylaxis. Patients who are allergic to one penicillin will be allergic to all.

See also

  • aminopenicillins
  • antipseudomonal penicillins
  • beta-lactamase inhibitors
  • natural penicillins
  • penicillinase resistant penicillins

Drug List:


Wednesday, October 19, 2016

Secubar Diu




Secubar Diu may be available in the countries listed below.


Ingredient matches for Secubar Diu



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Secubar Diu in the following countries:


  • Spain

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Secubar Diu in the following countries:


  • Spain

International Drug Name Search


Dexamethasone Rosemont




Dexamethasone Rosemont may be available in the countries listed below.


Ingredient matches for Dexamethasone Rosemont



Dexamethasone

Dexamethasone is reported as an ingredient of Dexamethasone Rosemont in the following countries:


  • Greece

International Drug Name Search


Osteorel




Osteorel may be available in the countries listed below.


Ingredient matches for Osteorel



Calcium Phosphate

Calcium Phosphate is reported as an ingredient of Osteorel in the following countries:


  • Greece

International Drug Name Search


Omnipaque 140


See also: Generic Omnipaque 180, Generic Omnipaque 240, Generic Omnipaque 300, Generic Omnipaque 350


Omnipaque 140 is a brand name of iohexol, approved by the FDA in the following formulation(s):


OMNIPAQUE 140 (iohexol - injectable; injection)



  • Manufacturer: GE HEALTHCARE

    Approval date: November 30, 1988

    Strength(s): 30.2% [RLD]

Has a generic version of Omnipaque 140 been approved?


No. There is currently no therapeutically equivalent version of Omnipaque 140 available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Omnipaque 140. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Omnipaque 140.

See also...


    Sintel




    Sintel may be available in the countries listed below.


    Ingredient matches for Sintel



    Albendazole

    Albendazole is reported as an ingredient of Sintel in the following countries:


    • Bangladesh

    International Drug Name Search


    Vicks Vaposteam




    In the US, Vicks Vaposteam (camphor topical) is a member of the drug class miscellaneous topical agents.

    US matches:

    • Vicks VapoSteam Liquid

    Ingredient matches for Vicks Vaposteam



    Camphor

    Camphor is reported as an ingredient of Vicks Vaposteam in the following countries:


    • United States

    International Drug Name Search


    Doxicin




    Doxicin may be available in the countries listed below.


    Ingredient matches for Doxicin



    Doxycycline

    Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxicin in the following countries:


    • Poland

    International Drug Name Search


    Hypertrophic Cardiomyopathy Medications


    Definition of Hypertrophic Cardiomyopathy: Hypertrophic cardiomyopathy (HCM) is a form of cardiomyopathy (disease of the heart muscle) involving enlargement and thickening of the heart muscle. This enlargement interferes with the function of the heart. More...

    Drugs (by generic name) associated with Hypertrophic Cardiomyopathy

    The following drugs and medications are in some way related to, or used in the treatment of Hypertrophic Cardiomyopathy. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    Topics under Hypertrophic Cardiomyopathy

    • Idiopathic Hypertrophic Subaortic Stenosis (7 drugs)

    Learn more about Hypertrophic Cardiomyopathy





    Drug List:


    Seboclear




    Seboclear may be available in the countries listed below.


    Ingredient matches for Seboclear



    Minocycline

    Minocycline is reported as an ingredient of Seboclear in the following countries:


    • Argentina

    Minocycline hydrochloride (a derivative of Minocycline) is reported as an ingredient of Seboclear in the following countries:


    • Argentina

    International Drug Name Search


    Solanax




    Solanax may be available in the countries listed below.


    Ingredient matches for Solanax



    Alprazolam

    Alprazolam is reported as an ingredient of Solanax in the following countries:


    • Japan

    International Drug Name Search


    Silverol




    Silverol may be available in the countries listed below.


    Ingredient matches for Silverol



    Sulfadiazine

    Sulfadiazine silver (a derivative of Sulfadiazine) is reported as an ingredient of Silverol in the following countries:


    • Israel

    International Drug Name Search


    Dexkétoprofène




    Dexkétoprofène may be available in the countries listed below.


    Ingredient matches for Dexkétoprofène



    Dexketoprofen

    Dexkétoprofène (DCF) is also known as Dexketoprofen (Rec.INN)

    International Drug Name Search

    Glossary

    DCFDénomination Commune Française
    Rec.INNRecommended International Nonproprietary Name (World Health Organization)

    Click for further information on drug naming conventions and International Nonproprietary Names.

    DynaCirc




    In the US, DynaCirc (isradipine systemic) is a member of the drug class calcium channel blocking agents and is used to treat Angina Pectoris Prophylaxis, High Blood Pressure and Raynaud's Syndrome.

    US matches:

    • DynaCirc CR Extended-Release Tablets

    • Dynacirc

    • Dynacirc CR

    Ingredient matches for DynaCirc



    Isradipine

    Isradipine is reported as an ingredient of DynaCirc in the following countries:


    • Colombia

    • Guyana

    • Hong Kong

    • Malaysia

    • New Zealand

    • Singapore

    • South Africa

    • Taiwan

    • Thailand

    • United States

    International Drug Name Search


    Tuesday, October 18, 2016

    Obmet




    Obmet may be available in the countries listed below.


    Ingredient matches for Obmet



    Metformin

    Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Obmet in the following countries:


    • Sri Lanka

    International Drug Name Search


    Zyrtec


    Zyrtec is a brand name of cetirizine, approved by the FDA in the following formulation(s):


    ZYRTEC (cetirizine hydrochloride - syrup; oral)



    • Manufacturer: MCNEIL CONSUMER

      Approval date: September 27, 1996

      Strength(s): 5MG/5ML [RLD][AA]

    Has a generic version of Zyrtec been approved?


    Yes. The following products are equivalent to Zyrtec:


    cetirizine hydrochloride syrup; oral



    • Manufacturer: AMNEAL PHARMS

      Approval date: October 7, 2009

      Strength(s): 5MG/5ML [AA]


    • Manufacturer: APOTEX INC

      Approval date: June 18, 2008

      Strength(s): 5MG/5ML [AA]


    • Manufacturer: AUROBINDO PHARMA

      Approval date: December 16, 2009

      Strength(s): 5MG/5ML [AA]


    • Manufacturer: CYPRESS PHARM

      Approval date: October 6, 2008

      Strength(s): 5MG/5ML [AA]


    • Manufacturer: DR REDDYS LABS LTD

      Approval date: April 27, 2009

      Strength(s): 5MG/5ML [AA]


    • Manufacturer: PERRIGO R AND D

      Approval date: June 17, 2008

      Strength(s): 5MG/5ML [AA]


    • Manufacturer: RANBAXY

      Approval date: June 18, 2008

      Strength(s): 5MG/5ML [AA]


    • Manufacturer: SUN PHARM INDS INC

      Approval date: November 12, 2009

      Strength(s): 5MG/5ML [AA]


    • Manufacturer: TARO

      Approval date: June 20, 2008

      Strength(s): 5MG/5ML [AA]


    • Manufacturer: TEVA PHARMS

      Approval date: May 27, 2008

      Strength(s): 5MG/5ML [AA]


    • Manufacturer: VINTAGE

      Approval date: September 25, 2009

      Strength(s): 5MG/5ML [AA]


    • Manufacturer: WOCKHARDT

      Approval date: August 28, 2009

      Strength(s): 5MG/5ML [AA]

    Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zyrtec. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

    See also: About generic drugs.




    Related Patents

    There are no current U.S. patents associated with Zyrtec.

    See also...

    • Zyrtec Consumer Information (Drugs.com)
    • Zyrtec Consumer Information (Wolters Kluwer)
    • Zyrtec Chewable Tablets Consumer Information (Wolters Kluwer)
    • Zyrtec Syrup Consumer Information (Wolters Kluwer)
    • ZyrTEC Dissolve Consumer Information (Cerner Multum)
    • ZyrTEC Liquid Gels Consumer Information (Cerner Multum)
    • Zyrtec Consumer Information (Cerner Multum)
    • Zyrtec AHFS DI Monographs (ASHP)
    • Cetirizine Consumer Information (Drugs.com)
    • Cetirizine Consumer Information (Wolters Kluwer)
    • Cetirizine Chewable Tablets Consumer Information (Wolters Kluwer)
    • Cetirizine Syrup Consumer Information (Wolters Kluwer)
    • Indoor/Outdoor Allergy Relief Consumer Information (Cerner Multum)
    • Cetirizine Consumer Information (Cerner Multum)
    • Cetirizine Hydrochloride AHFS DI Monographs (ASHP)

    Thalassemia Medications


    There are currently no drugs listed for "Thalassemia".

    Definition of Thalassemia: Thalassemias are hereditary disorders characterized by defective production of hemoglobin. This leads to low production, and over destruction, of red blood cells. More...

    Learn more about Thalassemia





    Drug List:


    Sandol




    Sandol may be available in the countries listed below.


    Ingredient matches for Sandol



    Tropicamide

    Tropicamide is reported as an ingredient of Sandol in the following countries:


    • Japan

    International Drug Name Search


    Monday, October 17, 2016

    Zumalin




    Zumalin may be available in the countries listed below.


    Ingredient matches for Zumalin



    Lincomycin

    Lincomycin hydrochloride monohydrate (a derivative of Lincomycin) is reported as an ingredient of Zumalin in the following countries:


    • Indonesia

    International Drug Name Search


    Seizure Prophylaxis During or Following Neurosurgery Medications


    There are currently no drugs listed for "Seizure Prophylaxis During or Following Neurosurgery". See Neurosurgery.





    Drug List:


    Fungal Infection Prophylaxis Medications


    Drugs associated with Fungal Infection Prophylaxis

    The following drugs and medications are in some way related to, or used in the treatment of Fungal Infection Prophylaxis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





    Drug List:


    Hermolepsin Retard




    Hermolepsin Retard may be available in the countries listed below.


    Ingredient matches for Hermolepsin Retard



    Carbamazepine

    Carbamazepine is reported as an ingredient of Hermolepsin Retard in the following countries:


    • Sweden

    International Drug Name Search


    NyoGel




    NyoGel may be available in the countries listed below.


    UK matches:

    • Nyogel 0.1% Eye Gel
    • Nyogel 0.1% Eye Gel (SPC)

    Ingredient matches for NyoGel



    Timolol

    Timolol is reported as an ingredient of NyoGel in the following countries:


    • Ireland

    Timolol maleate (a derivative of Timolol) is reported as an ingredient of NyoGel in the following countries:


    • Australia

    • Belgium

    • France

    • Germany

    • Greece

    • Italy

    • Luxembourg

    • Netherlands

    • Portugal

    • South Africa

    • United Kingdom

    International Drug Name Search

    Glossary

    SPC Summary of Product Characteristics (UK)

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Sunday, October 16, 2016

    Soventol HydroCort




    Soventol HydroCort may be available in the countries listed below.


    Ingredient matches for Soventol HydroCort



    Hydrocortisone

    Hydrocortisone is reported as an ingredient of Soventol HydroCort in the following countries:


    • Germany

    Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Soventol HydroCort in the following countries:


    • Germany

    International Drug Name Search


    Omep




    Omep may be available in the countries listed below.


    Ingredient matches for Omep



    Omeprazole

    Omeprazole is reported as an ingredient of Omep in the following countries:


    • Bangladesh

    • Brazil

    • Estonia

    • Germany

    • India

    • Latvia

    • Lithuania

    • Luxembourg

    • Myanmar

    • Serbia

    • Sri Lanka

    International Drug Name Search


    Degan




    Degan may be available in the countries listed below.


    Ingredient matches for Degan



    Metoclopramide

    Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Degan in the following countries:


    • Bulgaria

    • Czech Republic

    • Slovakia

    International Drug Name Search


    Q-Pin




    Q-Pin may be available in the countries listed below.


    Ingredient matches for Q-Pin



    Quetiapine

    Quetiapine fumarate (a derivative of Quetiapine) is reported as an ingredient of Q-Pin in the following countries:


    • Croatia (Hrvatska)

    International Drug Name Search


    Nufadipect




    Nufadipect may be available in the countries listed below.


    Ingredient matches for Nufadipect



    Bromhexine

    Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Nufadipect in the following countries:


    • Indonesia

    Guaifenesin

    Guaifenesin is reported as an ingredient of Nufadipect in the following countries:


    • Indonesia

    International Drug Name Search


    Otosil




    Otosil may be available in the countries listed below.


    Ingredient matches for Otosil



    Promethazine

    Promethazine hydrochloride (a derivative of Promethazine) is reported as an ingredient of Otosil in the following countries:


    • Bangladesh

    International Drug Name Search


    Hyponatremia Medications


    Definition of Hyponatremia: Hyponatremia refers to a low concentration of sodium in the blood and occurs when athletes sweat profusely and then drink copious amounts of pure water to replenish fluids, without adequately replacing electrolytes. It occurs more frequently during endurance events that last longer than several hours, where athletes attempting to rehydrate over several hours of exertion may end up compounding the problem without realizing it.

    Drugs associated with Hyponatremia

    The following drugs and medications are in some way related to, or used in the treatment of Hyponatremia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    Topics under Hyponatremia

    • Euvolemic Hyponatremia (2 drugs)

    Learn more about Hyponatremia





    Drug List:


    Saturday, October 15, 2016

    Octreotide




    In some countries, this medicine may only be approved for veterinary use.


    In the US, Octreotide (octreotide systemic) is a member of the drug class somatostatin and somatostatin analogs and is used to treat Acromegaly, Carcinoid Tumor, Diabetes - Type 1, Diarrhea, Gastrinoma, Glucagonoma, Insulinoma, Pituitary Adenoma, Small Bowel or Pancreatic Fistula and Vasoactive Intestinal Peptide Tumor.

    US matches:

    • Octreotide

    • Octreotide Kit

    • Octreotide injectable

    • Octreotide Injection, Intramuscular

    • Octreotide Acetate

    UK matches:

    • Octreotide Mayne
    • Octreotide 100microgram / ml solution for injection (SPC)
    • Octreotide 200micrograms / ml solution for injection (SPC)
    • Octreotide 50 micrograms/1 ml Solution for injection (SPC)
    • Octreotide 500 micrograms/1 ml Solution for Injection (SPC)
    • Octreotide 500micrograms / ml solution for injection (SPC)
    • Octreotide 50micrograms / ml solution for injection (SPC)
    • Octreotide Hospira 100 micrograms/1 ml Solution for Injection (SPC)

    Scheme

    Rec.INN

    ATC (Anatomical Therapeutic Chemical Classification)

    H01CB02

    CAS registry number (Chemical Abstracts Service)

    0083150-76-9

    Chemical Formula

    C49-H66-N10-O10-S2

    Molecular Weight

    1019

    Therapeutic Categories

    Hemostatic agent, gastrointestinal tract

    Growth hormone release inhibiting hormone analogue (analogue of somatostatin)

    Chemical Name

    D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamido cyclic (2-7) disulfide

    Foreign Names

    • Octreotidum (Latin)
    • Octreotid (German)
    • Octréotide (French)
    • Octreotida (Spanish)

    Generic Names

    • Octreotide (OS: BAN, USAN)
    • Octréotide (OS: DCF)
    • SMS 201-995 (IS: Sandoz)
    • Octreotide Acetate (OS: BANM, JAN, USAN)
    • SMS 201-995 ac (IS)

    Brand Names

    • Acrotid
      Sun Pharma, Peru


    • Azestan
      AC Farma, Peru


    • Cryostatin
      Cryopharma, Mexico


    • Longastatina
      Italfarmaco, Italy


    • Nomactril
      Ivax, Mexico


    • Octreotida Tosicina
      Support Pharma, Spain


    • Octreotide Mayne
      Hospira Nordic, Denmark


    • Octride
      Chalver, Colombia; Sun, Myanmar


    • Samilstin
      LPB, Italy


    • Sandostatin
      Novartis, Argentina; Novartis, Austria; Novartis, Bosnia & Herzegowina; Novartis, Bulgaria; Novartis, Chile; Novartis, Czech Republic; Novartis, Denmark; Novartis, Spain; Novartis, Greece; Novartis, Hong Kong; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, India; Novartis, Iceland; Novartis, Luxembourg; Novartis, Latvia; Novartis, Malta; Novartis, Norway; Novartis, New Zealand; Novartis, Romania; Novartis, Serbia; Novartis, Russian Federation; Novartis, Thailand; Novartis, Turkey; Novartis, Taiwan; Novartis, Venezuela; Novartis, South Africa; Novartis Pharma, Vietnam; Novartis Pharmaceuticals, Peru


    • Sandostatin (veterinary use)
      Novartis Animal Health, United Kingdom


    • Sandostatin LAR
      Novartis, Australia; Novartis, Ecuador; Novartis, Indonesia; Novartis, Turkey; Novartis, Taiwan


    • Sandostatina
      Novartis, Italy; Novartis, Portugal


    • Sandostatine
      Novartis, Tunisia


    • Bendatreotid
      Bendalis, Germany


    • Longastatina LAR
      Italfarmaco, Italy


    • Octreotid Hexal
      Hexal, Germany


    • Octreotide Acetate
      APP, United States; Bedford, United States; Hospira, Australia; Sun, United States; Teva USA, United States


    • Octreotide Hospira
      Hospira, Netherlands; Hospira, Norway; Hospira, New Zealand; Hospira Nordic, Sweden


    • Octréotide Hospira
      Hospira, France


    • Octreotide Sandoz
      Sandoz, Netherlands


    • Octreotide
      Hospira, Italy


    • Sandostatin Euro
      Euro, Netherlands


    • Sandostatin
      Novartis, Australia; Novartis, Canada; Novartis, Switzerland; Novartis, China; Novartis, Germany; Novartis, Estonia; Novartis, Finland; Novartis, United Kingdom; Novartis, Georgia; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Ireland; Novartis, Japan; Novartis, Sri Lanka; Novartis, Lithuania; Novartis, Malaysia; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Serbia; Novartis, Sweden; Novartis, Slovenia; Novartis, Slovakia; Novartis, United States


    • Sandostatin LAR
      Novartis, Argentina; Novartis, Austria; Novartis, Brazil; Novartis, Switzerland; Novartis, Chile; Novartis, China; Novartis, Colombia; Novartis, Czech Republic; Novartis, Germany; Novartis, Denmark; Novartis, Spain; Novartis, United Kingdom; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Iceland; Novartis, Italy; Novartis, Japan; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Malta; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Russian Federation; Novartis, Sweden; Novartis, Singapore; Novartis, Slovenia; Novartis, United States; Novartis, Venezuela; Novartis Pharmaceuticals, Peru


    • Sandostatina LAR
      Novartis, Bulgaria


    • Sandostatine LAR
      Medcor, Netherlands; Novartis, Netherlands


    • Sandostatine
      EU-Pharma, Netherlands; Novartis, Belgium; Novartis, France; Novartis, Netherlands

    International Drug Name Search

    Glossary

    BANBritish Approved Name
    BANMBritish Approved Name (Modified)
    DCFDénomination Commune Française
    ISInofficial Synonym
    JANJapanese Accepted Name
    OSOfficial Synonym
    Rec.INNRecommended International Nonproprietary Name (World Health Organization)
    SPC Summary of Product Characteristics (UK)
    USANUnited States Adopted Name

    Click for further information on drug naming conventions and International Nonproprietary Names.